FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
|Articles|May 12, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of May 12, 2021
Author(s)Sydney Jennings
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 vaccinations, cases, and deaths in the US and on cases and deaths worldwide.
Advertisement
How many people in the US have been vaccinated against COVID-19?
According to the US
• 46.4% of total US population has received at least 1 dose
• 35.4% of total US population is fully vaccinated
• 35.4% of total US population is fully vaccinated
The 5 states with the highest percentage of population fully vaccinated are:
1. Maine: 46.6%
2. Connecticut: 45.9%
3. Vermont: 44.4%
4. Massachusetts: 44.1%
5. Rhode Island: 42.8%
2. Connecticut: 45.9%
3. Vermont: 44.4%
4. Massachusetts: 44.1%
5. Rhode Island: 42.8%
How many cases of COVID-19 have been confirmed in the US?
According to the
• 32 789 989 confirmed cases
• 583 141 deaths
• 583 141 deaths
The 5 states with the highest total confirmed cases are:
1. California: 3 761 955
2. Texas: 2 920 719 3. Florida: 2 275 365
4. New York: 2 076 312
5. Illinois: 1 357 843
2. Texas: 2 920 719 3. Florida: 2 275 365
4. New York: 2 076 312
5. Illinois: 1 357 843
Deaths: California has the most deaths due to COVID-19 with 62 387 reported fatalities, followed by New York with 52 817, and Texas with 50 725.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 159 845 155 confirmed cases, 3 321 212 deaths, and 95 897 262 recoveries.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.
FDA acceptance starts review of clesrovimab for second-season RSV prevention in high-risk children younger than 2 years.
Endocrine Society statement highlights key research gaps on obesity drugs—who benefits, long-term dosing, safety, and measuring success beyond weight loss.
Advertisement
Advertisement
Trending on Patient Care Online
1
ASH Raises Ferritin Thresholds for Diagnosing Iron Deficiency
2
FDA Approves Finerenone for CKD Associated With Type 1 Diabetes
3
Combating Prostate Cancer Misconceptions in Primary Care: An Expert Discussion
4
FAQ: What the Endocrine Society’s New Scientific Statement Means for Obesity Treatment
5